Expanded access to publicly subsidised lisdexamfetamine treatment for adults with attention-deficit/hyperactivity disorder: An interrupted time-series analysis

Aust N Z J Psychiatry. 2023 Jul;57(7):1073-1076. doi: 10.1177/00048674231170556. Epub 2023 Apr 25.

Claudia Bruno¹, Helga Zoega^{1

2}, Malcolm B Gillies¹, Alys Havard^{1

3}, David Coghill^{4

5}, Sallie-Anne Pearson¹, Jonathan Brett¹

¹ School of Population Health, Faculty of Medicine & Health, University of New South Wales, Sydney, NSW, Australia.
² Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavík, Iceland.
³ National Drug and Alcohol Research Centre, Faculty of Medicine & Health, University of New South Wales, Sydney, NSW, Australia.
⁴ Departments of Paediatrics and Psychiatry, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC, Australia.
⁵ Murdoch Children's Research Institute, Melbourne, VIC, Australia.

No abstract available

Publication types